Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun 11;24(1):332.
doi: 10.1186/s13054-020-03052-9.

COVID-19: opening a new paradigm in thromboprophylaxis for critically ill patients?

Raquel Ferrandis  1 , Juan V Llau  2 , Manuel Quintana  3 , Pilar Sierra  4 , Francisco Hidalgo  5 , Concepción Cassinello  6 , Aurelio Gómez-Luque  7
Affiliations

COVID-19: opening a new paradigm in thromboprophylaxis for critically ill patients?

Raquel Ferrandis et al. Crit Care. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no potential competing interests.

Figures

Fig. 1
Fig. 1
Summary proposal diagram for the management of thromboprophylaxis in critically ill COVID-19 patients
See this image and copyright information in PMC

References

    1. Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up. J Am Coll Cardiol. 2020. 10.1016/j.jacc.2020.04.031. - PMC - PubMed
    1. Guan W, Ni Z, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708–20. - PMC - PubMed
    1. Jackson SP, Darbousset R, Schoenwaelder SM. Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanisms. Blood. 2019;133(9):906–918. doi: 10.1182/blood-2018-11-882993. - DOI - PubMed
    1. Paranjpe I, Fuster V, Lala A, Russak A, Glicksberg BS, Levin MA, et al. Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19. J Am Coll Cardiol 2020 Epublished. 10.1016/j.jacc.2020.05.001. - PMC - PubMed
    1. Llau JV, Ferrandis R, Sierra P, Hidalgo F, Cassinello C, Gómez-Luque A, et al. SEDAR-SEMICYUC consensus recommendations on the management of haemostasis disturbances in severe patients with SARS-CoV-2 infection [article in Spanish]. Rev Esp Anestesiol Reanim. 2020; (in press). 10.1016/j.redar.2020.05.007. - PMC - PubMed

MeSH terms

Substances